US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 01:52:57 Source：World Wanderer news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Hilarious moment mother asks her Cocker Spaniel to help choose her lottery numbers
- Next：Jude Bellingham's new model girlfriend Laura Celia Valk looks sensational in a figure
Related articles
- Baby Reindeer's real
- Vendor that mishandled Pennsylvania virus data to pay $2.7 million in federal whistleblower case
- Workers rule the streets on May Day
- Police stop knife attack in central Oslo after man stabs 1 person and threatens others
- Siblings trying to make US water polo teams for Paris Olympics
- Hurricanes avoid major injury for DeAngelo and close in on getting Pesce back for Rangers series
- Rangers rookie Matt Rempe doesn't mind playing the villain role in the NHL playoffs
- Stuart Fairchild's sensational catch robs Manny Machado of a 3
- David Ortiz is humbled by being honored in New York again; this time for post
- Adames homers twice with 4 RBIs, Brewers beat Rays 7
- Tourism boosts China's social, economic development
- Adames homers twice with 4 RBIs, Brewers beat Rays 7
- Kenta Maeda gets first win for Tigers, 4
- Deion Sanders, son respond to social media criticisms over how coach handled transfers at Colorado
- Wildfires sweep across Finland, straining rescue services
- New US sanctions against Russia target weapons development, ban uranium imports for nuclear power
- Baby Reindeer stars Richard Gadd and Jessica Gunning are arm
- Lugo gets 5th win in 7 starts, Massey adds 3
- Messi in and Dybala out in Argentina squad for pre
- Hurricanes avoid major injury for DeAngelo and close in on getting Pesce back for Rangers series
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,World Wanderer news portal sitemap